Virasoft Corporation

Virasoft Corporation is a medical technology company based in Istanbul, Türkiye, with a presence in New York. Founded in 2015, the company specializes in AI-powered digital pathology solutions aimed at enhancing cancer diagnosis and optimizing laboratory workflows. Virasoft offers a range of products, including APLIS, which manages laboratory workflows to streamline specimen handling, and synoptic reporting tools like the Bethesda Synoptic Checklist for improved diagnostic consistency. Their AI-driven diagnostic products include Tubule-U-Net, a deep learning framework for breast cancer image analysis, and integrated decision support tools for clinical diagnosis. The company is committed to improving patient outcomes through accessible technologies and aims to enable 30% of pathologists in target markets to adopt their solutions within five years. Virasoft collaborates with partners like Pathoteam Diagnostic and has raised a total of $4.4 million in funding. They prioritize customer success, innovation, and accountability in their mission to transform pathology practices globally.